Pfizer Inc. (PFE):企業のM&A・提携動向(医療機器分野)

GlobalDataが発行した調査報告書(GDME32190D)
◆英語タイトル:Pfizer Inc. (PFE) - Medical Equipment - Deals and Alliances Profile
◆商品コード:GDME32190D
◆発行会社(リサーチ会社):GlobalData
◆発行日:2016年2月24日
◆ページ数:119
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary

Pfizer Inc. (Pfizer) is a biopharmaceutical company, which focuses on the discovery, development, manufacture and marketing of healthcare products such as medicines, vaccines and consumer health care products. It offers products for the treatment of respiratory, cardiovascular and metabolic diseases and conditions, infection, inflammation, cancer, ophthalmic diseases, neurological problems, pain, tissue repair, gastrointestinal diseases, women’s health issues, orphan diseases and genitourinary infections, among others. The company also develops small molecules, biologics and vaccines. Pfizer sells prescription pharmaceutical products through wholesalers, besides selling them directly to retailers, hospitals, clinics, government agencies and pharmacies. It sells consumer healthcare products through pharmacies, retail chains, distributors and grocery and convenience stores. The company has operations across the Americas, Asia-Pacific, Europe and the Middle East and Africa. Pfizer is headquartered in New York, the US.

Pfizer Inc. (PFE) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
Pfizer Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 7
Pfizer Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 8
Pfizer Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 9
Pfizer Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 10
Pfizer Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 11
Pfizer Inc., Medical Equipment, Deal Details 14
Asset Purchase 14
Pfizer May Sell Infusion Pump Business of Hospira 14
Venture Financing 15
UE LifeSciences to Raise USD0.1 Million in Seed Financing 15
InnoPharma Secures US$15 Million In Series A Financing Round 17
U-Systems Secures US$6.5 Million In Venture Financing Round 19
U-Systems Raises US$10 Million In Financing Round 21
Partnerships 23
Ichor Medical Systems Enters Into Licensing Agreement With Pfizer 23
pSivida Amends Licensing Agreement With Pfizer 24
Mirth Enters Into Licensing Agreement With Pfizer Health Solutions 25
Thermo Fisher Scientific Enters into Agreement with Novartis and Pfizer 26
Merck and Pfizer Enters into Agreement with Dako 27
Thermo Fisher Scientific Enters into Co-Development Agreement with GlaxoSmithKline and Pfizer 29
Siemens Healthcare Enters Into Co-Development Agreement With Pfizer 31
Protagen Enters Into Biomarker Discovery Agreement With Pfizer 32
MaRS Innovation Enters Into Partnership With Pfizer 33
Dako Enters Into Agreement With Pfizer For Companion Diagnostics 34
Hospira Enters Into Distribution Agreement With Q Core Medical For Sapphire Infusion System 35
Humedica Enters Into Agreement With Pfizer 36
Stellar Pharma Enters Into Co-Marketing Agreement With Pfizer Canada For Gelfoam 37
Ventana Medical Systems Enters Into Co-Development Agreement With Pfizer 38
ICU Medical Extends Distribution Agreement With Hospira For CLAVE And Oncology Products 40
ICU Medical Extends Distribution Agreement With Hospira For Infusion Sets 41
Qiagen Enters Into Co-Development Agreement With Pfizer 42
Hospira Enters Into An Agreement With Smiths Medical 44
Hospira Enters Into Agreement With University of Alabama at Birmingham 45
Pfizer Enters Into Co-Development Agreement With DxS 46
Mylan Specialty Enters Into Licensing Agreement With Pfizer For EpiPen 47
Abbott Labs Enters Into Licensing Agreement With Pfizer 49
Kiadis Pharma Enters Into Licensing Agreement With Hospira For ATIR 50
Debt Offering 51
Hospira Completes Debt Offering Of Senior Notes Due 2040 For US$500 Million 51
Asset Transactions 53
Pfizer May Sell Infusion Pump Business of Hospira 53
Mylan Completes Acquisition Of Respiratory Delivery Platform From Pfizer For US$348 Million 54
True Process Acquires VeriScan, Bar Code And Radio-Frequency Identification System From Hospira 56
SEDLine Acquires SEDLine Brain Function Monitoring Business From Hospira 57
Acquisition 58
Allergan and Pfizer to Combine in USD160 Billion Deal 58
Pfizer Acquires Hospira for USD17 Billion 61
Pfizer May Acquire Remaining 90.5% Stake in Cellectis 64
Pfizer May Increase Bid to Acquire AstraZeneca 65
Premier Acquires TheraDoc from Hospira for USD117 Million 67
Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb 68
Covidien Completes Acquisition Of superDimension, Pulmonary Device Maker, For US$300 Million 70
Pfizer Inc. – Key Competitors 73
Key Employees 74
Locations And Subsidiaries 77
Head Office 77
Other Locations & Subsidiaries 77
Recent Developments 102
Financial Announcements 102
Feb 02, 2016: Pfizer Reports Fourth-Quarter And Full-Year 2015 Results Provides 2016 Financial Guidance 102
Jul 28, 2015: Pfizer Reports Second-Quarter 2015 Results 107
Corporate Communications 112
Feb 08, 2016: Pfizer Names Executive Leadership Team for Combined Organization Upon Close of Proposed Allergan Transaction 112
Jun 25, 2015: Joseph J. Echevarria Elected To Pfizer’s Board Of Directors 113
Other Significant Developments 114
Oct 27, 2015: Pfizer Reports Third-Quarter 2015 Results 114
Appendix 119
Methodology 119
About GlobalData 119
Contact Us 119
Disclaimer 119

List of Tables
Pfizer Inc., Medical Equipment, Key Facts, 2015 1
Pfizer Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 1
Pfizer Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 7
Pfizer Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 8
Pfizer Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 9
Pfizer Inc., Deals By Market, 2010 to YTD 2016 10
Pfizer Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 11
Pfizer May Sell Infusion Pump Business of Hospira 14
UE LifeSciences to Raise USD0.1 Million in Seed Financing 15
InnoPharma Secures US$15 Million In Series A Financing Round 17
U-Systems Secures US$6.5 Million In Venture Financing Round 19
U-Systems Raises US$10 Million In Financing Round 21
Ichor Medical Systems Enters Into Licensing Agreement With Pfizer 23
pSivida Amends Licensing Agreement With Pfizer 24
Mirth Enters Into Licensing Agreement With Pfizer Health Solutions 25
Thermo Fisher Scientific Enters into Agreement with Novartis and Pfizer 26
Merck and Pfizer Enters into Agreement with Dako 27
Thermo Fisher Scientific Enters into Co-Development Agreement with GlaxoSmithKline and Pfizer 29
Siemens Healthcare Enters Into Co-Development Agreement With Pfizer 31
Protagen Enters Into Biomarker Discovery Agreement With Pfizer 32
MaRS Innovation Enters Into Partnership With Pfizer 33
Dako Enters Into Agreement With Pfizer For Companion Diagnostics 34
Hospira Enters Into Distribution Agreement With Q Core Medical For Sapphire Infusion System 35
Humedica Enters Into Agreement With Pfizer 36
Stellar Pharma Enters Into Co-Marketing Agreement With Pfizer Canada For Gelfoam 37
Ventana Medical Systems Enters Into Co-Development Agreement With Pfizer 38
ICU Medical Extends Distribution Agreement With Hospira For CLAVE And Oncology Products 40
ICU Medical Extends Distribution Agreement With Hospira For Infusion Sets 41
Qiagen Enters Into Co-Development Agreement With Pfizer 42
Hospira Enters Into An Agreement With Smiths Medical 44
Hospira Enters Into Agreement With University of Alabama at Birmingham 45
Pfizer Enters Into Co-Development Agreement With DxS 46
Mylan Specialty Enters Into Licensing Agreement With Pfizer For EpiPen 47
Abbott Labs Enters Into Licensing Agreement With Pfizer 49
Kiadis Pharma Enters Into Licensing Agreement With Hospira For ATIR 50
Hospira Completes Debt Offering Of Senior Notes Due 2040 For US$500 Million 51
Pfizer May Sell Infusion Pump Business of Hospira 53
Mylan Completes Acquisition Of Respiratory Delivery Platform From Pfizer For US$348 Million 54
True Process Acquires VeriScan, Bar Code And Radio-Frequency Identification System From Hospira 56
SEDLine Acquires SEDLine Brain Function Monitoring Business From Hospira 57
Allergan and Pfizer to Combine in USD160 Billion Deal 58
Pfizer Acquires Hospira for USD17 Billion 61
Pfizer May Acquire Remaining 90.5% Stake in Cellectis 64
Pfizer May Increase Bid to Acquire AstraZeneca 65
Premier Acquires TheraDoc from Hospira for USD117 Million 67
Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb 68
Covidien Completes Acquisition Of superDimension, Pulmonary Device Maker, For US$300 Million 70
Pfizer Inc., Key Competitors 73
Pfizer Inc., Key Employees 74
Pfizer Inc., Other Locations 77
Pfizer Inc., Subsidiaries 77

List of Figures
Pfizer Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016 1
Pfizer Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 1
Pfizer Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 1
Pfizer Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 1
Pfizer Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 7
Pfizer Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016 8
Pfizer Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 9
Pfizer Inc., Medical Equipment, Deals by Market, 2010 to YTD 2016 10

【掲載企業】

Johnson & Johnson
Actavis plc
Sanofi
Eli Lilly and Company
Merck & Co., Inc.
Bristol-Myers Squibb Company
Amgen Inc.
Synthetic Biologics, Inc.
Durata Therapeutics, Inc.
Mallinckrodt plc
Tesaro, Inc.
Cardiome Pharma Corp
NewLink Genetics Corporation
Bellus Health Inc.
Cempra, Inc.
Sophiris Bio, Inc.
SunHealth Solutions
Pernix Therapeutics Holdings, Inc.
Nutex Nyrt.
Karessa Pharma Holding AB
Capstone Therapeutics Corp.

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Pfizer Inc. (PFE):企業のM&A・提携動向(医療機器分野)(Pfizer Inc. (PFE) - Medical Equipment - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆